These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27496147)

  • 21. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
    Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
    Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
    Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
    Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fifty years of phenylketonuria newborn screening - A great success for many, but what about the rest?
    Groselj U; Tansek MZ; Battelino T
    Mol Genet Metab; 2014; 113(1-2):8-10. PubMed ID: 25174964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National Institutes of Health (NIH) to host a consensus development conference on screening and management for phenylketonuria (PKU).
    Pediatr Nurs; 2000; 26(5):539. PubMed ID: 12026348
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of neonatal screening programme for phenylketonuria.
    Smith I; Cook B; Beasley M
    BMJ; 1991 Aug; 303(6798):333-5. PubMed ID: 1912773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylketonuria detected by the neonatal screening program in Thailand.
    Pangkanon S; Ratrisawadi V; Charoensiriwatana W; Techasena W; Boonpuan K; Srisomsap C; Svasti J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():179-81. PubMed ID: 15906730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical practice guidelines for phenylketonuria].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Huang S; Song F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):226-234. PubMed ID: 32128737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria.
    Ceglarek U; Müller P; Stach B; Bührdel P; Thiery J; Kiess W
    Clin Chem Lab Med; 2002 Jul; 40(7):693-7. PubMed ID: 12241016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening for inborn errors of metabolism: a systematic review.
    Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
    Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening.
    Gu X; Wang Z; Ye J; Han L; Qiu W
    Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):107-4. PubMed ID: 19904469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review.
    El-Metwally A; Yousef Al-Ahaidib L; Ayman Sunqurah A; Al-Surimi K; Househ M; Alshehri A; Da'ar OB; Abdul Razzak H; AlOdaib AN
    Biomed Res Int; 2018; 2018():7697210. PubMed ID: 29850564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study.
    Toktaş İ; Sarıbaş S; Canpolat S; Erdem Ö; Özbek MN
    Turk J Pediatr; 2022; 64(6):985-992. PubMed ID: 36583880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of newborn screening.
    Levy PA
    J Dev Behav Pediatr; 2010 Sep; 31(7):622-31. PubMed ID: 20814260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [History and prospect of the neonatal screening program for inborn errors of metabolism].
    Gu XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):321-4. PubMed ID: 15924741
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of Tandem Mass Spectrometry and the Fluorometric Method-Parallel Phenylalanine Measurement on a Large Fresh Sample Series and Implications for Newborn Screening for Phenylketonuria.
    Perko D; Groselj U; Cuk V; Iztok Remec Z; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Repic Lampret B
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenylketonuria in South Africa. A report on the status quo.
    Hitzeroth HW; Niehaus CE; Brill DC
    S Afr Med J; 1995 Jan; 85(1):33-6. PubMed ID: 7784915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the phenylketonuria screening programme in Estonia.
    Ounap K; Lilleväli H; Metspalu A; Lipping-Sitska M
    J Med Screen; 1998; 5(1):22-3. PubMed ID: 9575455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn feeding and screening for phenylketonuria.
    Ponzone A; Spada M; Ferrero GB; Ponzone R; Ferraris S
    Acta Paediatr; 1999 Mar; 88(3):347-8. PubMed ID: 10229052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.